Ajit Mishra, vice president, Research, Religare Broking, answers your stock market queries.
Sun Pharma and Dr Reddy's top list in terms of those who face most class-action litigation
Gaurav Garg, Head of Research, CapitalVia answers readers' stock market queries
Telangana chief minister K Chandrasekhar Rao on Wednesday announced the establishment of a massive industrial park dedicated to pharmaceutical manufacturing activities.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Drugs under exemption make up roughly 95 per cent of the antiretrovirals used by India's AIDS patients
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
With sales of over Rs 12,240 crore in nine months of the current financial year, it is ahead of Rs 11,580 crore recorded by Lupin but behind Sun Pharma, which reported Rs 19,350 crore sales.
Quite a few large- and mid-cap stocks are yet to recover from the note ban, pharma, banking and rural demand-based industries among laggards.
With a new higher tax regime coming into effect from the new financial year, top corporates and wealthy investors are in a rush to restructure their shareholding.
Top companies added employees at 3% CAGR from 2003-04 to 2013-14, while revenues grew at 18%.
After spending considerable time and energy in remediation efforts in the wake of the US Food and Drug Administration's warning letter on compliance issues, the company's leadership has finally set out to bring the house in order.
The country had the third-largest number of people living with disease.
Ajit Mishra, Vice President, Research, Religare Broking, answers readers' stock market queries. Ajit will offer his unbiased views on a weekly basis
FIIs are looking at the long-term story and initiatives of Indian pharma companies to transform themselves into global entities.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Gaurav Garg, Head of Research, CapitalVia answers readers' stock market queries.
Life in Telangana is likely to come to a standstill on Tuesday, thanks to the state government's Intensive Household Survey. Not just the state-owned public transport buses, even private vehicles, will remain off the roads.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Expectations of strong results, consistent performance and investors preference for stocks in the defensive space help the sector outshine broader markets.
Audit firms such as KPMG believe zero complaints may be an indicator of the lack of requisite mechanism to allow for such reporting
Rise in investor sentiment, return of risk appetite aid shares across the board
Big bull's holdings cross Rs 7,200 crore (Rs 72 billion).
Large and small businesses alike have delivered low-key performances.
Index heavyweight RIL surged 3% to end above Rs 1,000 mark while IT majors were also the top gainers.
FDA allows Teva to launch Nexium generic; Cipla, which supplies formulation, to gain
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Natco Pharma, Wockhardt and Marksans have rallied between 50 and 70 per cent in the year till date.
The country's drug companies have attracted the highest number of enforcements from the American drug regulator in 2013, a year that has seen the US Food and Drug Administration turning stricter to ensure compliance levels and quality of medicines.
In a big shot in the arm for the YSR Congress party in Andhra Pradesh, a Central Bureau of Investigation court in Hyderabad on Monday granted conditional bail to its president and Member of Lok Sabha YS Jaganmohan Reddy in disproportionate assets case.
Ajit Mishra, Vice President, Research, Religare Broking, answers readers's queries on stocks they own or want to buy.
Revival in domestic business should also help overall revenue growth.
The number of small units has come down drastically, as large companies have expanded their manufacturing capacity.
Market breadth continued to remain strong, with 1899 gainers and 674 losers on the BSEs.
Investors turn their attention to export-driven sectors.
The policy statement by the RBI governor is also expected to be upbeat.
Investors remain cautious ahead of F&O expiry.
Ajit Mishra, Vice President, Research, Religare Broking, answers readers' queries on stocks they own or want to buy.
And when an inspector asked about the contents of unlabelled vials in the laboratory glassware washing area, a plant worker dumped them down a sink and said the contents could not be determined, according to a July 18 letter from the US Food and Drug Administration to Wockhardt, which makes sterile injectable drugs and various forms of insulin.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances